1.
miR-155表达与手术切除的pⅢ期NSCLC的临床病理特征联系
Correlation of miR-155 expression with clinicopathologic characteristics of resected stage Ⅲ NSCLC
| Characteristic | n | miR-155 | χ2 | P | |
| Low expression | High expression | ||||
| *: Mann-Whitney U test; NSCLC: non-small cell lung cancer. | |||||
| Age (year) | 0.451 | 0.595 | |||
| ≤60 | 117 | 51 | 66 | ||
| >60 | 45 | 17 | 28 | ||
| Gender | 0.237 | 0.682 | |||
| Male | 133 | 57 | 76 | ||
| Female | 29 | 11 | 18 | ||
| Smoking index | 0.223 | 0.744 | |||
| ≤400 | 63 | 25 | 38 | ||
| >400 | 99 | 43 | 56 | ||
| Histology | 0.001 | 0.980 | |||
| Squamous carcinoma | 105 | 44 | 61 | ||
| Adenocarcinoma | 57 | 24 | 33 | ||
| Pathological stage | 1.486 | 0.312 | |||
| Ⅲa | 131 | 58 | 73 | ||
| Ⅲb | 31 | 10 | 21 | ||
| T stage | 1.738 | 0.619 | |||
| 1 | 2 | 0 | 2 | ||
| 2 | 50 | 20 | 30 | ||
| 3 | 46 | 21 | 25 | ||
| 4 | 64 | 27 | 37 | ||
| Nodal status | * | 0.032 | |||
| 0 | 28 | 18 | 10 | ||
| 1 | 26 | 10 | 16 | ||
| 2 | 108 | 40 | 68 | ||